vyscoxa

Generic: celecoxib

Labeler: carwin pharmaceutical associates, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vyscoxa
Generic Name celecoxib
Labeler carwin pharmaceutical associates, llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

celecoxib 10 mg/mL

Manufacturer
Carwin Pharmaceutical Associates, LLC

Identifiers & Regulatory

Product NDC 15370-501
Product ID 15370-501_28480106-933c-452e-acfd-75e1fe7179e4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA211759
Listing Expiration 2026-12-31
Marketing Start 2025-07-31

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 15370501
Hyphenated Format 15370-501

Supplemental Identifiers

RxCUI
2721529 2721535
UNII
JCX84Q7J1L
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vyscoxa (source: ndc)
Generic Name celecoxib (source: ndc)
Application Number NDA211759 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (15370-501-16)
source: ndc

Packages (1)

Ingredients (1)

celecoxib (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "28480106-933c-452e-acfd-75e1fe7179e4", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["JCX84Q7J1L"], "rxcui": ["2721529", "2721535"], "spl_set_id": ["5094d47e-f791-4190-9397-b7500143a74d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Carwin Pharmaceutical Associates, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (15370-501-16)", "package_ndc": "15370-501-16", "marketing_start_date": "20250731"}], "brand_name": "VYSCOXA", "product_id": "15370-501_28480106-933c-452e-acfd-75e1fe7179e4", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "15370-501", "generic_name": "Celecoxib", "labeler_name": "Carwin Pharmaceutical Associates, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VYSCOXA", "active_ingredients": [{"name": "CELECOXIB", "strength": "10 mg/mL"}], "application_number": "NDA211759", "marketing_category": "NDA", "marketing_start_date": "20250731", "listing_expiration_date": "20261231"}